{"id":"https://openalex.org/W2082469727","doi":"https://doi.org/10.1592/phco.21.12.133s.34507","title":"Antifungal Pharmacodynamics: Concentration\u2010Effect Relationships in Vitro and in Vivo","display_name":"Antifungal Pharmacodynamics: Concentration\u2010Effect Relationships in Vitro and in Vivo","alternate_titles":[],"publication_year":2001,"publication_date":"2001-08-01","ids":{"openalex":"https://openalex.org/W2082469727","doi":"https://doi.org/10.1592/phco.21.12.133s.34507","mag":"2082469727","pmid":"https://pubmed.ncbi.nlm.nih.gov/11501987"},"language":"en","primary_location":{"id":"doi:10.1592/phco.21.12.133s.34507","doi":"https://doi.org/10.1592/phco.21.12.133s.34507","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.21.12.133s.34507","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2082469727"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032935188","display_name":"Andreas H. Groll","orcid":"https://orcid.org/0000-0003-1188-393X","observed_orcids":["https://orcid.org/0000-0003-1188-393X"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andreas H. Groll","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA","Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA","institution_ids":["https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063738784","display_name":"Stephen C. Piscitelli","orcid":"https://orcid.org/0000-0002-4528-3273","observed_orcids":["https://orcid.org/0000-0002-4528-3273"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210155647","display_name":"National Institutes of Health Clinical Center","ror":"https://ror.org/04vfsmv21","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen C. Piscitelli","raw_affiliation_strings":["Pharmacokinetics Research Laboratory, Pharmacy Department, Warren Grant Magnuson Clinical Center (Dr. Piscitelli), National Institutes of Health, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacokinetics Research Laboratory, Pharmacy Department, Warren Grant Magnuson Clinical Center (Dr. Piscitelli), National Institutes of Health, Bethesda, Maryland","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210155647"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071800632","display_name":"Thomas J. Walsh","orcid":"https://orcid.org/0000-0002-4142-8711","observed_orcids":["https://orcid.org/0000-0002-4142-8711"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Walsh","raw_affiliation_strings":["Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5032935188"],"corresponding_institution_ids":["https://openalex.org/I4210140884"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":0.9061,"has_fulltext":false,"cited_by_count":74,"citation_normalized_percentile":{"value":0.63278689,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"21","issue":"8P2","first_page":"133S","last_page":"148S"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antifungal-agents","display_name":"antifungal agents","score":0.8970000147819519},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9739999771118164},{"id":"https://openalex.org/keywords/concentration-response-relationship","display_name":"concentration-dependent effects","score":0.8629999756813049},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6700000166893005},{"id":"https://openalex.org/keywords/susceptibility-breakpoints","display_name":"susceptibility breakpoints","score":0.8849999904632568},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.9089999794960022},{"id":"https://openalex.org/keywords/invasive-fungal-infections","display_name":"invasive fungal infections","score":0.875},{"id":"https://openalex.org/keywords/immunocompromised-patients","display_name":"immunocompromised patients","score":0.9789999723434448},{"id":"https://openalex.org/keywords/antifungal-prophylaxis","display_name":"antifungal prophylaxis","score":0.859000027179718},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.5860000252723694}],"concepts":[{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.8757691383361816},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7648147940635681},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.7573570013046265},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6773318648338318},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5881716012954712},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4096923768520355},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.37793320417404175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3443121016025543},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2779778242111206},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.22280052304267883},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.11657935380935669},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.08870819211006165}],"mesh":[{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002175","descriptor_name":"Candida","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002175","descriptor_name":"Candida","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011090","descriptor_name":"Polyenes","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011090","descriptor_name":"Polyenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011500","descriptor_name":"Protein Synthesis Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1592/phco.21.12.133s.34507","doi":"https://doi.org/10.1592/phco.21.12.133s.34507","is_oa":false,"landing_page_url":"https://doi.org/10.1592/phco.21.12.133s.34507","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:11501987","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11501987","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":100,"referenced_works":["https://openalex.org/W63281979","https://openalex.org/W1507662931","https://openalex.org/W1525050661","https://openalex.org/W1778098547","https://openalex.org/W1882135885","https://openalex.org/W1960875750","https://openalex.org/W1966921342","https://openalex.org/W1968406074","https://openalex.org/W1971531537","https://openalex.org/W1971920484","https://openalex.org/W1978263354","https://openalex.org/W1979783103","https://openalex.org/W1986064608","https://openalex.org/W1988840268","https://openalex.org/W1996225900","https://openalex.org/W2002716519","https://openalex.org/W2005143601","https://openalex.org/W2009091919","https://openalex.org/W2010620588","https://openalex.org/W2012705723","https://openalex.org/W2016541887","https://openalex.org/W2017253392","https://openalex.org/W2020136924","https://openalex.org/W2020985135","https://openalex.org/W2023020781","https://openalex.org/W2027359723","https://openalex.org/W2030094646","https://openalex.org/W2039639863","https://openalex.org/W2043751393","https://openalex.org/W2044337142","https://openalex.org/W2045393193","https://openalex.org/W2045476496","https://openalex.org/W2047133769","https://openalex.org/W2048976125","https://openalex.org/W2056691921","https://openalex.org/W2063213326","https://openalex.org/W2063572784","https://openalex.org/W2065419430","https://openalex.org/W2068884766","https://openalex.org/W2069801130","https://openalex.org/W2070051071","https://openalex.org/W2072785474","https://openalex.org/W2076088898","https://openalex.org/W2083356192","https://openalex.org/W2084979997","https://openalex.org/W2086627262","https://openalex.org/W2096792374","https://openalex.org/W2098898162","https://openalex.org/W2099898008","https://openalex.org/W2099953336","https://openalex.org/W2102170000","https://openalex.org/W2104445943","https://openalex.org/W2105749407","https://openalex.org/W2107531307","https://openalex.org/W2108989058","https://openalex.org/W2111523051","https://openalex.org/W2113237293","https://openalex.org/W2115072457","https://openalex.org/W2115769369","https://openalex.org/W2115958412","https://openalex.org/W2118628629","https://openalex.org/W2119596469","https://openalex.org/W2121999268","https://openalex.org/W2124339021","https://openalex.org/W2124424991","https://openalex.org/W2124458223","https://openalex.org/W2128233528","https://openalex.org/W2128801749","https://openalex.org/W2129639901","https://openalex.org/W2134458167","https://openalex.org/W2135053160","https://openalex.org/W2136377130","https://openalex.org/W2137115238","https://openalex.org/W2137351715","https://openalex.org/W2137375011","https://openalex.org/W2137924703","https://openalex.org/W2140831280","https://openalex.org/W2142854079","https://openalex.org/W2145481868","https://openalex.org/W2147492397","https://openalex.org/W2148877718","https://openalex.org/W2153400187","https://openalex.org/W2153735119","https://openalex.org/W2154671988","https://openalex.org/W2156250275","https://openalex.org/W2157088595","https://openalex.org/W2158893183","https://openalex.org/W2160204310","https://openalex.org/W2160355967","https://openalex.org/W2162128591","https://openalex.org/W2163238436","https://openalex.org/W2164811538","https://openalex.org/W2165952048","https://openalex.org/W2168307793","https://openalex.org/W2168781246","https://openalex.org/W2172068234","https://openalex.org/W2312655781","https://openalex.org/W2330529379","https://openalex.org/W3189204461","https://openalex.org/W4229696946"],"related_works":["https://openalex.org/W2016154413","https://openalex.org/W1972629088","https://openalex.org/W2416233554","https://openalex.org/W4211225659","https://openalex.org/W2109311072","https://openalex.org/W2128612529","https://openalex.org/W7097772129","https://openalex.org/W2017132965","https://openalex.org/W7143309847","https://openalex.org/W1994529604"],"abstract_inverted_index":{"The":[0],"pharmacodynamics":[1,59],"of":[2,22,26,29,56,60,75,79,103],"antifungal":[3,61,90],"compounds":[4],"involve":[5],"relationships":[6,31],"among":[7],"drug":[8,45],"concentrations,":[9],"time,":[10],"and":[11,16,43,58,72,81,86,101],"antimicrobial":[12],"effects":[13],"in":[14,17,52,84,108],"vitro":[15],"vivo.":[18],"Beyond":[19],"better":[20],"understanding":[21],"a":[23],"drug's":[24],"mode":[25],"action,":[27],"characterization":[28],"these":[30],"has":[32],"important":[33,94],"implications":[34],"for":[35],"setting":[36],"susceptibility":[37],"breakpoints,":[38],"establishing":[39],"rational":[40],"dosing":[41],"regimens,":[42],"facilitating":[44],"development.":[46],"Important":[47],"advances":[48],"have":[49],"been":[50],"made":[51],"the":[53,99],"experimental":[54,85],"investigation":[55],"pharmacokinetics":[57],"drugs;":[62],"however,":[63],"much":[64],"remains":[65],"to":[66],"be":[67],"learned":[68],"about":[69],"specific":[70,73],"pathogens":[71],"sites":[74],"infection.":[76],"Increased":[77],"incorporation":[78],"pharmacokinetic":[80],"pharmacodynamic":[82],"principles":[83],"clinical":[87],"studies":[88],"with":[89],"agents":[91],"is":[92],"an":[93],"objective":[95],"that":[96],"will":[97],"benefit":[98],"treatment":[100],"prophylaxis":[102],"life-threatening":[104],"invasive":[105],"fungal":[106],"infections":[107],"immunocompromised":[109],"patients.":[110]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2082469727","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
